FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE.
Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.
This more particularly include the GIP ARRONAX, the laboratories Ceisam, CEMA-Oniris, CRCI2NA, LS2N, Subatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.
Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.
our publications
18F-FDG-Based Radiomics and Machine Learning. Godefroy T, Frécon G, Asquier-Khati A, Mateus D, Lecomte R, Rizkallah M, et al., JACC: Cardiovascular Imaging. avr 2023;S1936878X23000931. https://doi.org/10.1016/j.jcmg.2023.01.020
- 18ffdg-based radiomics and machine learning: a useful help for aortic prosthetic valve infective endocarditis diagnosis?, Thomas Godefroy, Gauthier Frécon, Antoine Asquier-Khati, Diana Mateus, Raphael Lecomte, Mira Rizkallah, Nicolas Piriou, Thomas Le Tourneau, David Boutoille, Thomas Eugene and Thomas Carlier, European Heart Journal, 43(Supplement 2):ehac544–318, 2022
http://dx.doi.org/10.1093/eurheartj/ehac544.318
our news
![[Agenda] NET Symposium of RHU OPERANDI on neuroendocrine tumours](/wp-content/uploads/2023/05/logo-RHU_OPERANDI-270x200.png){kind=logo}
[Agenda] NET Symposium of RHU OPERANDI on neuroendocrine tumours
24/05/23
Program Registration Alexandre Lugat, physician in the nuclear medicine department of the Nantes University Hospital, will lecture on …
Read more
Keerthana Kamalakannan’s work awarded at ARCEBS 2023
03/05/23
Keerthana Kamalakannan won the best talk award at the Fifth International Conference on Application of RadiotraCers and Energetic …
Read more
ISI NucMed 2023 : registration is open !
07/02/23
Next July in Nantes, 20 PhD students, young researchers and clinicians will deepen their knowledge in some of …
Read more
The Nantes astatine project selected by the European Research Council
06/02/23
François Guérard, INSERM UMR 1307 / CNRS UMR 6075, CRCI2NA, Centre de Recherche en Cancérologie et Immunologie Intégrée …
Read more
APUI passes 100th patient dose milestone
09/11/22
On November 8, 2022, a patient in a clinical trial led by the ICO received a dose of …
Read more![[Agenda] 15th workshop of the “Tumour Targeting, Imaging, Radiotherapies” network](/wp-content/uploads/2022/10/bandeau-workshop-vir-270x200.jpg)
[Agenda] 15th workshop of the “Tumour Targeting, Imaging, Radiotherapies” network
03/10/22
From October 5 to 8, 2022, the fifteenth workshop of the "Tumour Targeting, Imaging, Radiotherapies" network of the …
Read moreOur equipments
